EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 27.26 and traded as low as GBX 25.50. EKF Diagnostics shares last traded at GBX 25.50, with a volume of 71,332 shares trading hands.
EKF Diagnostics Trading Up 0.8%
The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The business’s 50 day simple moving average is GBX 25.35 and its 200 day simple moving average is GBX 27.26. The stock has a market cap of £111.02 million, a P/E ratio of 18.89 and a beta of 0.57.
Insider Activity at EKF Diagnostics
In related news, insider Julian Baines purchased 85,000 shares of the firm’s stock in a transaction that occurred on Monday, December 15th. The shares were acquired at an average price of GBX 23 per share, with a total value of £19,550. 39.62% of the stock is owned by company insiders.
About EKF Diagnostics
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Featured Stories
- Five stocks we like better than EKF Diagnostics
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
